The Department of Defense announced new opportunities for American businesses to advance biotechnology as part of President Biden’s efforts to strengthen and build the resiliency of America’s defense industrial base and secure its supply chains. Biomanufacturing has the potential to support the U.S. military and our allies and partners by generating needed materials — from fuels and chemicals to food and medical supplies — where and when our forces need them has significant implications for our military.
This Request for White Papers (RWP) for the Distributed Bioindustrial Manufacturing Investment Program (DBMIP) seeks to strengthen domestic supply chains and sustain America’s global prominence in biotechnology. The DBMIP will execute investments through the Defense Industrial Base Consortium (DIBC) Other Transaction Agreement (OTA), which helps lower barriers to allow the DoD to work more expeditiously with small, nontraditional, and large businesses.
“President Biden called on the Department of Defense to assess how the agency can use biotechnology to make our supply chains more resilient, create jobs at home, and strengthen America’s bioeconomy,” said Heidi Shyu, Under Secretary of Defense for Research and Engineering. “These major investments will help answer his charge to harness the full potential and power of biotechnology to advance national and economic security.”